rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
We developed a new model of PD that combines a sub-toxic MPTP insult to the G2019S-LRRK2 mutation.
|
31813996 |
2020 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
1.Available evidence confirms that the LRRK2 variant rs34637584 is associated with less cognitive impairment in people with PD.2.GBA variants rs76763715 and rs421016 are associated with more severe cognitive impairment in people with PD.3.The GBA variants rs76763715, rs421016, rs387906315 and rs80356773 have been significantly associated with the onset of depressive symptoms in PD.
|
31292011 |
2020 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Mutations in the gene encoding leucine-rich repeat kinase 2 (<i>LRRK2</i>), such as the G2019S mutation, are the most common cause of familial Parkinson's disease (PD).
|
31373835 |
2020 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
The G2019S substitution in the kinase domain of LRRK2 (LRRK2<sup>G2019S</sup>) is the most prevalent mutation associated with Parkinson's disease (PD).
|
31605779 |
2020 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
The most prevalent PD associated mutation, LRRK2-G2019S</span> is linked to familial and sporadic cases.
|
31621607 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
These findings demonstrate an important role for LRRK2 protein in regulation of mitochondrial clearance by the lysosomes, which is hampered in PD with the G2019S mutation.
|
31261377 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Reduced integrity of non-motor networks was detected among NMC of the G2019S mutation in the LRRK2 gene prior to identifiable changes in connectivity of the motor network, indicating significant non-motor cerebral changes among populations "at risk" for future development of PD.
|
30793410 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
In examining the effects of PD-associated mutations and risk factors on protein function, we found that conserved substitutions such as G2019S affect human and mouse LRRK2 proteins similarly, but variation around position 2385, which is not fully conserved between humans and mice, induces divergent in vitro behavior.
|
30291536 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
CSF samples of 51 subjects were analyzed: 15 LRRK2 p.G2019S PD, 10 IPD, 16 LRRK2 p.G2019S nonmanifesting carriers (NMC) and 10 healthy controls.
|
31211166 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
The G2019S LRRK2 mutation, the commonest mutation in PD worldwide, was found in 5.7% of patients with idiopathic PD and 17.6% of familial cases in 153 Uzbek patients.
|
31485304 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
We applied an event-related fMRI gambling task to a group of non-manifesting carriers (NMC) of the G2019S mutation in the LRRK2 gene, in order to assess the reward network in an "at risk" population for future development of PD.
|
29971685 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Neurite Collapse and Altered ER Ca<sup>2+</sup> Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation.
|
30595548 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
We found that closely matched PD patient groups with the LRRK2-G2019S mutation (PD-LRRK2) or GBA1 variants (PD-GBA) expressed the same disease networks as sporadic disease (sPD), but PD-LRRK2 and PD-GBA patients exhibited abnormal increases in network connectivity that were not present in sPD.
|
31813991 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Conversely, α-syn aggregation increased in primary neurons from mice expressing the PD-linked LRRK2 G2019S mutation.
|
30927072 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Fibroblasts from PD patients (with or without the G2019S LRRK2 mutation) and control subjects were used to assess the different phenotypes between idiopathic and genetic PD.
|
30032424 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
This study predicts the molecular pathogenicity mechanism of the G2019S on patients with PD and provides a potential platform for developing therapeutics for patients with PD that harbor this amino acid substitution.
|
30844370 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
G2019S variant is rare in Asian populations, whereas two other Asian-specific LRRK2 variants, G2385R and R1628P, are more frequent with a twofold increased risk of PD.
|
31041581 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Generation of gene-corrected iPSC line, KIOMi002-A, from Parkinson's disease patient iPSC with LRRK2 G2019S mutation using BAC-based homologous recombination.
|
31731184 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Here, we defined the mechanism by which LRRK2-G2019S (LRRK2-GS), a pathogenic mutation in the PD-associated gene LRRK2, accelerates ER stress and cell death.
|
31046837 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Increased cancer risk has been reported in Parkinson's disease (PD) patients carrying the leucine rich repeat kinase 2 (LRRK2) G2019S mutation (LRRK2-PD) in comparison with idiopathic PD (IPD).
|
31348549 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Data was collected from 1525 Ashkenazi Jews diagnosed with PD from the Tel-Aviv Medical center; 161 G2019S-LRRK2-PD, 222 GBA-PD, and 1142 iPD (no G2019S-LRRK2 or any of the 7 AJ GBA mutations tested).
|
31164863 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Mice expressing Lrrk2 carrying the Parkinson's disease-linked p.G2019S mutation controlled infection better, with reduced bacterial growth and longer animal survival during sepsis.
|
31554740 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Frequency of the LRRK2 G2019S mutation in South African patients with Parkinson's disease.
|
31493133 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Among the several LRRK2 pathogenic mutations, the most prevalent G2019S mutation increases its kinase activity when compared with the wild-type (WT), suggesting that LRRK2 kinase substrates are potential culprits of PD pathogenesis.
|
31138985 |
2019 |
rs34637584
|
|
|
0.900 |
GeneticVariation |
BEFREE |
G2019S Variation in LRRK2: An Ideal Model for the Study of Parkinson's Disease?
|
31551736 |
2019 |